Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Serum Thymidine Kinase Activity in Diagnosis,Prognosis and Monitoring of Treatment in Patients With Solid Tumors

NCT01050413 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01050413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01050413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Serum Thymidine Kinase Activity in Diagnosis,Prognosis and Monitoring of Treatment in Patients With Solid Tumors
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2010
Completion date
December 31, 2011
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors